The Purpose of the Study is to Continue to Provide Pemigatinib to Patients With Advanced Malignancies.
About the study
Safety and tolerability of pemigatinib.in monotherapy or combination in patients that have participated in a previous parent study to treat advanced malignancies.
Who can take part
You may be eligible to participate in the study if you meet the following criteria:
INCLUSION CRITERIA
Inclusion Criteria:
- Currently enrolled and receiving treatment in an Incyte-sponsored clinical study (parent protocol) of pemigatinib as monotherapy or combination therapy.
- Currently benefiting from and tolerating treatment with pemigatinib, as determined by the investigator.
- Demonstrated compliance, as assessed by the investigator, with the parent protocol requirements.
- Willingness and ability to comply with scheduled visits, treatment plans, and any other study procedures.
- Currently have no evidence of progressive disease, as determined by the investigator, following treatment with pemigatinib as monotherapy or combination therapy.
- Willingness to avoid pregnancy or fathering children.
EXCLUSION CRITERIA
Exclusion Criteria:
- Able to access pemigatinib commercially or outside of a clinical trial.
- Permanently discontinued from the parent protocol for any reason.
- Women who are pregnant or breastfeeding or participants expecting to conceive or father children within the projected duration of the study.
No longer meet the inclusion/exclusion criteria from the parent protocol if still receiving treatment.
Study Locations
Enter your ZIP code/Postal code/PIN code to locate study sites near you:
How to Apply
Contact the study center to learn if this study is a good match for you.
Study’s details
Contition
Advanced Malignancies
Age (in years)
18 - 90
Phase
Phase 2
Participants needed
10
Est. Completion Date
Dec 29, 2023
Treatment type
Interventional
Sponsor
Incyte Corporation
ClinicalTrials.gov identifier
NCT04949191
Study number
INCB 54828-801
Understanding Clinical Trials
Get answers to your questions about clinical trials.What is a clinical research?What does taking part in clinical trials involve?What should I ask the trial doctor?